Skip to content

Posts tagged ‘consultant’

Why does sorafenib work in HCC but sunitinib does not?

January 24th, 2011

Daedalus

Published by Sally Church on Pharma Strategy Blog

New advances in triple negative breast cancer

January 10th, 2011

Daedalus

Published by Sally Church on Pharma Strategy Blog

New cystic fibrosis drug offers hope

December 30th, 2010

Daedalus

Published by Pieter Droppert on Biotech Strategy Blog

Update on circulating tumor cells in colorectal cancer

December 29th, 2010

Daedalus

Published by Sally Church on Pharma Strategy Blog

FDA to review Avid Radipharmaceuticals Imaging Biomarker for Alzheimer's Disease

December 27th, 2010

Daedalus

Published by Pieter Droppert on Biotech Strategy Blog

My impressions of ASH

December 22nd, 2010

Daedalus

Published by Pieter Droppert on Biotech Strategy Blog

Pharma Strategy Blog named as blog to watch in 2011

December 21st, 2010

Daedalus

Thanks to Priya Kapor of Ogilvy PR for including Pharma Strategy Blog as one her 11 Pharma Blogs for 2011 that have “not only walked the walk but have helped shaped this space in the past year and most likely will moving into 2011.”

Screen shot 2010 12 21 at 12.51.27 PM Pharma Strategy Blog named as blog to watch in 2011

Targeting BAP1 – a future targeted therapy for Uveal Melanoma?

December 21st, 2010

Daedalus

Published by Pieter Droppert on Biotech Strategy Blog

JNJ files NDA for abiraterone in castration resistant prostate cancer

December 20th, 2010

Daedalus

Published by Sally Church on Pharma Strategy Blog

Can teriparatide be used to treat osteonecrosis of the jaw?

December 20th, 2010

Daedalus

Published on Biotech Strategy Blog by Pieter Droppert